论文信息 - Durable Efficacy of Enfuvirtide Over 48 Weeks in Heavily Treatment-Experienced HIV-1-Infected Patients in the T-20 Versus Optimized Background Regimen Only 1 and 2 Clinical Trials - 字舞流文

Durable Efficacy of Enfuvirtide Over 48 Weeks in Heavily Treatment-Experienced HIV-1-Infected Patients in the T-20 Versus Optimized Background Regimen Only 1 and 2 Clinical Trials

J. Montaner | B. Clotet | D. Kuritzkes | H. Stellbrink | C. Katlama | D. Cooper | A. Lazzarin | S. Walmsley | C. Cohen | J. Eron | M. Nelson | J. Delfraissy | J. Lange | J. Lalezari | J. Reynes | K. Arastéh | K. Henry | N. Buss | B. Trottier | M. Salgo | M. O'Hearn | P. Piliero | Jain Chung | R. Demasi | Lucille Donatacci | C. Wat | D. Guimaraes | L. Smiley | Martin Wilkinson | Adeline Valentine | Denise Guimaraes